Newton J A, Camplejohn R S, Bowyer C, McGibbon D H, Wright N A
Dermatologica. 1985;171(6):469-73. doi: 10.1159/000249475.
Epidermal cell proliferation in psoriasis was studied after oral methotrexate using tritiated uridine. Psoriatic enteropathy has in the past been reported to reduce the absorption of methotrexate administered orally but this study showed that the onset of inhibition of mitosis and DNA synthesis occurred at the same time as after intramuscular administration of the drug. The cell kinetic data indicate that cells were blocked at the G1/S interface, and the kinetics of inhibition are discussed in terms of their implications for the mode of action of methotrexate in psoriasis. Considerable numbers of dead cells were seen in the epidermis from 6 to 24 h after oral methotrexate. The mode of action of methotrexate in psoriasis is currently unknown but whatever other actions it may have, any global hypothesis of its action will have to incorporate a flux to epidermal cell death.
使用氚标记的尿苷研究了口服甲氨蝶呤后银屑病表皮细胞的增殖情况。过去有报道称银屑病性肠病会降低口服甲氨蝶呤的吸收,但该研究表明,有丝分裂和DNA合成的抑制开始时间与肌肉注射该药物后相同。细胞动力学数据表明细胞在G1/S界面被阻断,并根据其对甲氨蝶呤在银屑病中作用模式的影响讨论了抑制动力学。口服甲氨蝶呤后6至24小时,在表皮中可见大量死亡细胞。目前尚不清楚甲氨蝶呤在银屑病中的作用模式,但无论它可能有其他什么作用,其作用的任何整体假说都必须考虑到表皮细胞死亡的通量。